Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Genky DrugStores Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥3,445.00 |
52 Week High | JP¥3,540.00 |
52 Week Low | JP¥2,462.50 |
Beta | 0 |
11 Month Change | 26.14% |
3 Month Change | 18.79% |
1 Year Change | 36.71% |
33 Year Change | 62.88% |
5 Year Change | 238.91% |
Change since IPO | 64.05% |
Recent News & Updates
Shareholder Returns
9267 | JP Consumer Retailing | JP Market | |
---|---|---|---|
7D | -2.1% | -5.5% | -10.6% |
1Y | 36.7% | -5.7% | 7.2% |
Return vs Industry: 9267 exceeded the JP Consumer Retailing industry which returned -5.7% over the past year.
Return vs Market: 9267 exceeded the JP Market which returned 7.2% over the past year.
Price Volatility
9267 volatility | |
---|---|
9267 Average Weekly Movement | 6.2% |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.2% |
10% most volatile stocks in JP Market | 9.8% |
10% least volatile stocks in JP Market | 3.3% |
Stable Share Price: 9267 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9267's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 1,753 | Kenichi Fujinaga | www.genkydrugstores.co.jp |
Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.
Genky DrugStores Co., Ltd. Fundamentals Summary
9267 fundamental statistics | |
---|---|
Market cap | JP¥104.37b |
Earnings (TTM) | JP¥6.32b |
Revenue (TTM) | JP¥184.86b |
16.6x
P/E Ratio0.6x
P/S RatioIs 9267 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9267 income statement (TTM) | |
---|---|
Revenue | JP¥184.86b |
Cost of Revenue | JP¥147.24b |
Gross Profit | JP¥37.62b |
Other Expenses | JP¥31.30b |
Earnings | JP¥6.32b |
Last Reported Earnings
Jun 20, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 208.14 |
Gross Margin | 20.35% |
Net Profit Margin | 3.42% |
Debt/Equity Ratio | 65.3% |
How did 9267 perform over the long term?
See historical performance and comparison